Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-in…

Overview of attention for article published in BMC Cancer, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 1 news story.

NEW YORK ─ French diagnostic test developer OncoDiag has commenced commercialization of its first test, a multiplex, real-time…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.